Thursday, June 6

Regenerative Medicine & Cellular Therapy

Session IA

7:55 – 9:50 AM

The Potential of Cord Blood Stem Cells for Use in Regenerative Medicine

Chair: Mahendra Rao

7:55 – 8:10 AM Welcome and Introduction

Joanne Kurtzberg, MD, Duke University

8:10 – 8:30 AM What are the Opportunities for Cord Blood Derived Products in Regenerative Medicine?

Mahendra Rao, MD, PhD, National Institutes of Health Center for Regenerative Medicine

8:30 – 8:50 AM Deriving Mesenchymal Stem Cells from Human Amniotic Fluid: Potential for an Allogeneic Cellular Therapy Product

Julie G. Allickson, PhD, MS, MT(ASCP), Wake Forest University

8:50 – 9:20 AM MSC-like Cells from Human Umbilical Cord Tissue: Roadmap to Clinical Utility in Regenerative Therapies

Morey Kraus, Perkin Elmer/ViaCord

9:20 – 9:50 AMEx Vivo Modulation Strategies to Enhance the Therapeutic Potential of Cord Blood

Dan Shoemaker, PhD, Fate Therapeutics

9:50 – 10:10 AM


Session IB

10:10 AM – 12:00 PM

Using Cord Blood to Heal the Brain

Chairs: Sidhartha Tan & Wise Young

10:10 – 10:30 AMEfficacy of Cord Blood Stem Cells in a Baby Rabbit Model of Hypoxic-Ischemic Encephalopathy

Sidhartha Tan, MD, University of Chicago

10:30 – 10:50 AMCombined Hematopoietic Stem Cell Transplantation, Gene and Substrate Reduction Therapy Show Superior Results to HSCT in a Murine Model of Krabbe Disease

Mark Sands, PhD, Washington University School of Medicine in St. Louis

10:50 – 11:10 AMUmbilical Cord Blood Mononuclear Cell Therapy of Spinal Cord Injury, Stroke, Myocardial Infarction, and Optic Nerve Atrophy

Wise Young, MD, PhD, Rutgers University

11:10 – 11:30 AMHigh Resolution Tracktography is a Highly Sensitive Biomarker to Study Myelination in the Brain

Jessica Sun, MD, Duke University

11:30 – 12:00 PMDebate: Can Off-the-shelf Allogenic Cord Blood Products Bridge Hematopoiesis after Marrow Injury?

Colleen Delaney, MD, Fred Hutchinson Cancer Research Center

Joanne Kurtzberg, MD, Duke University

12:00 – 1:00 PM


Session IIA

1:00 – 2:50 PM

Envisioning the Future Landscape for Novel Applications of Cord Blood in Regenerative Medicine

Chairs: Julie Allickson & Andrew Balber

1:00 – 1:30 PMWhat is the Potential for Banked Cord Blood in the Field of Regenerative Medicine?

Joanne Kurtzberg, MD, Duke University

1:30 – 2:00 PMOvercoming Allogeneic Barriers to Cellular Therapies with Banked Cord Blood

Alison Willing, PhD, University of South Florida

2:00 – 2:30 PMDeriving Induced Pluripotent Stem Cells from Small Samples of Cryopreserved Cord Blood

Scott Noggle, PhD, New York Stem Cell Foundation

2:30 – 2:50 PMPanel Discussion - Rao, Allickson, Balber, Kurtzberg, Willing, Noggle
2:50 – 3:10 PM


Session IIB

3:10 – 5:00 PM

Cord Blood Transplantation for Non-Malignant Diseases

Chairs: Shalini Shenoy & Jennifer Willert

3:10 – 3:40 PMHematopoietic Stem-Cell Transplantation for Sickle Cell Disease

Shalini Shenoy, MD, Washington University School of Medicine in St. Louis

3:40 – 4:00 PMNicord for Cord Blood Transplantation in Patients with Sickle Cell Disease

Joanne Kurtzberg, MD, Duke University

4:00 – 4:20 PMLate Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome

Jaap Boelens, MD, PhD, University Medical Center Utrecht

4:20 – 4:40 PMFunctional Outcomes of Cord Blood Transplantation for Patients with Metachromatic Leukodystrophy

Maria Escolar, MD, MS, University of Pittsburgh School of Medicine

4:40 – 5:00 PMPanel Discussion - Shenoy, Willert, Kurtzberg, Boelens, Escolar
5:00 PM


View Friday's Program

StemCyte, Inc. China CordBlood Corporation National Marrow Donor Program/Be the Match

Support provided by